Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alessia Onali"'
Autor:
Daniela Secci, Erica Sanna, Simona Distinto, Alessia Onali, Antonio Lupia, Laura Demuru, Giulia Atzeni, Rita Meleddu, Filippo Cottiglia, Andrea Angeli, Claudiu T. Supuran, Elias Maccioni
Publikováno v:
Molecules, Vol 29, Iss 18, p 4444 (2024)
Human Carbonic Anhydrases (hCA) are enzymes that contribute to cancer’s development and progression. Isoforms IX and XII have been identified as potential anticancer targets, and, more specifically, hCA IX is overexpressed in hypoxic tumor cells, w
Externí odkaz:
https://doaj.org/article/df5f80cd728340e8a291dc5da994202e
Autor:
Karolína Salvadori, Alessia Onali, Gregory Mathez, Václav Eigner, Marcela Dendisová, Pavel Matějka, Monika Mullerová, Andrea Brancale, Petra Cuřínová
Publikováno v:
ACS Omega, Vol 8, Iss 46, Pp 44221-44228 (2023)
Externí odkaz:
https://doaj.org/article/bf2f95cd5b294dcdb4ce649fa02aa58c
Autor:
Lisa Sequeira, Simona Distinto, Rita Meleddu, Marco Gaspari, Andrea Angeli, Filippo Cottiglia, Daniela Secci, Alessia Onali, Erica Sanna, Fernanda Borges, Eugenio Uriarte, Stefano Alcaro, Claudiu T. Supuran, Elias Maccioni
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 38, Iss 1 (2023)
Tumour associated carbonic anhydrases (CAs) IX and XII have been recognised as potential targets for the treatment of hypoxic tumours. Therefore, considering the high pharmacological potential of the chromene scaffold as selective ligand of the IX an
Externí odkaz:
https://doaj.org/article/608a90cbda4941e490d99c961256b83c
Autor:
Rita Meleddu, Serenella Deplano, Elias Maccioni, Francesco Ortuso, Filippo Cottiglia, Daniela Secci, Alessia Onali, Erica Sanna, Andrea Angeli, Rossella Angius, Stefano Alcaro, Claudiu T. Supuran, Simona Distinto
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 685-692 (2021)
A small library of coumarin and their psoralen analogues EMAC10157a-b-d-g and EMAC10160a-b-d-g has been designed and synthesised to investigate the effect of structural modifications on their inhibition ability and selectivity profile towards carboni
Externí odkaz:
https://doaj.org/article/b4e1f0d1e7d5471eb96942409fad975f
Autor:
Rita Meleddu, Angela Corona, Simona Distinto, Filippo Cottiglia, Serenella Deplano, Lisa Sequeira, Daniela Secci, Alessia Onali, Erica Sanna, Francesca Esposito, Italo Cirone, Francesco Ortuso, Stefano Alcaro, Enzo Tramontano, Péter Mátyus, Elias Maccioni
Publikováno v:
Molecules, Vol 26, Iss 13, p 3821 (2021)
Current therapeutic protocols for the treatment of HIV infection consist of the combination of diverse anti-retroviral drugs in order to reduce the selection of resistant mutants and to allow for the use of lower doses of each single agent to reduce
Externí odkaz:
https://doaj.org/article/1ad3314eb0a74fe68b34c1c275aa5a3f
Autor:
Daniela Secci, Claudiu T. Supuran, Francesco Ortuso, Serenella Deplano, Andrea Angeli, Erica Sanna, Alessia Onali, Rita Meleddu, Filippo Cottiglia, Simona Distinto, Elias Maccioni, Stefano Alcaro, Rossella Angius
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 685-692 (2021)
article-version (VoR) Version of Record
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 685-692 (2021)
A small library of coumarin and their psoralen analogues EMAC10157a-b-d-g and EMAC10160a-b-d-g has been designed and synthesised to investigate the effect of structural modifications on their inhibition ability and selectivity profile towards carboni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad769a05d0bb6dbc8bb98843182f61e
Autor:
Erica Sanna, Serenella Deplano, Rita Meleddu, Francesco Ortuso, Simona Distinto, Angela Corona, Stefano Alcaro, Lisa Sequeira, Filippo Cottiglia, Elias Maccioni, Francesca Esposito, Daniela Secci, Alessia Onali, Péter Mátyus, Italo Cirone, Enzo Tramontano
Publikováno v:
Molecules
Volume 26
Issue 13
Molecules, Vol 26, Iss 3821, p 3821 (2021)
Volume 26
Issue 13
Molecules, Vol 26, Iss 3821, p 3821 (2021)
Current therapeutic protocols for the treatment of HIV infection consist of the combination of diverse anti-retroviral drugs in order to reduce the selection of resistant mutants and to allow for the use of lower doses of each single agent to reduce